$ALOT
AstroNova, Inc.

2015 Q4 Form 10-Q Financial Statement

#000119312515401329 Filed on December 11, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2014 Q4
Revenue $24.75M $23.14M
YoY Change 6.98% 27.27%
Cost Of Revenue $14.60M $12.99M
YoY Change 12.45% 20.05%
Gross Profit $10.15M $10.15M
YoY Change 0.0% 37.88%
Gross Profit Margin 41.01% 43.88%
Selling, General & Admin $6.454M $6.013M
YoY Change 7.33% 21.47%
% of Gross Profit 63.57% 59.23%
Research & Development $1.839M $1.564M
YoY Change 17.58% 27.15%
% of Gross Profit 18.11% 15.41%
Depreciation & Amortization $520.0K $500.0K
YoY Change 4.0% 61.29%
% of Gross Profit 5.12% 4.93%
Operating Expenses $8.293M $7.577M
YoY Change 9.45% 22.61%
Operating Profit $1.859M $2.575M
YoY Change -27.81% 117.67%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $333.0K -$46.00K
YoY Change -823.91% 2200.0%
Pretax Income $2.192M $2.529M
YoY Change -13.33% 114.14%
Income Tax $873.0K $974.0K
% Of Pretax Income 39.83% 38.51%
Net Earnings $1.319M $1.555M
YoY Change -15.18% 40.34%
Net Earnings / Revenue 5.33% 6.72%
Basic Earnings Per Share $0.18 $0.20
Diluted Earnings Per Share $0.18 $0.20
COMMON SHARES
Basic Shares Outstanding 7.295M shares 7.730M shares
Diluted Shares Outstanding 7.466M shares 7.926M shares

Balance Sheet

Concept 2015 Q4 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.50M $30.90M
YoY Change -27.18% -5.21%
Cash & Equivalents $11.30M $13.27M
Short-Term Investments $11.20M $17.60M
Other Short-Term Assets $6.900M $7.500M
YoY Change -8.0% -40.0%
Inventory $15.12M $16.42M
Prepaid Expenses
Receivables $14.91M $13.77M
Other Receivables $400.0K $400.0K
Total Short-Term Assets $59.79M $69.01M
YoY Change -13.37% 0.62%
LONG-TERM ASSETS
Property, Plant & Equipment $9.416M $8.265M
YoY Change 13.93% 7.02%
Goodwill $4.522M $991.0K
YoY Change 356.31% 24.65%
Intangibles $2.873M
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.75M $400.0K
YoY Change 2586.5% 300.0%
Total Long-Term Assets $20.16M $4.478M
YoY Change 350.25% 206.29%
TOTAL ASSETS
Total Short-Term Assets $59.79M $69.01M
Total Long-Term Assets $20.16M $4.478M
Total Assets $79.95M $81.75M
YoY Change -2.21% 5.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.375M $4.432M
YoY Change 21.28% 61.16%
Accrued Expenses $2.379M $5.500M
YoY Change -56.75% -12.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.20M $10.57M
YoY Change 15.46% -9.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.100M $1.000M
YoY Change 10.0% -23.08%
Total Long-Term Liabilities $1.100M $1.000M
YoY Change 10.0% -23.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.20M $10.57M
Total Long-Term Liabilities $1.100M $1.000M
Total Liabilities $13.34M $11.66M
YoY Change 14.42% -11.78%
SHAREHOLDERS EQUITY
Retained Earnings $41.90M $39.70M
YoY Change 5.53% 10.65%
Common Stock $45.20M $476.0K
YoY Change 9395.38% 3.25%
Preferred Stock
YoY Change
Treasury Stock (at cost) $19.66M $13.09M
YoY Change 50.16% 6.02%
Treasury Stock Shares 2.298M shares 1.776M shares
Shareholders Equity $66.61M $70.10M
YoY Change
Total Liabilities & Shareholders Equity $79.95M $81.75M
YoY Change -2.21% 5.12%

Cashflow Statement

Concept 2015 Q4 2014 Q4
OPERATING ACTIVITIES
Net Income $1.319M $1.555M
YoY Change -15.18% 40.34%
Depreciation, Depletion And Amortization $520.0K $500.0K
YoY Change 4.0% 61.29%
Cash From Operating Activities $4.090M $4.440M
YoY Change -7.88% 270.0%
INVESTING ACTIVITIES
Capital Expenditures -$880.0K -$850.0K
YoY Change 3.53% 57.41%
Acquisitions
YoY Change
Other Investing Activities $3.890M -$2.750M
YoY Change -241.45% -574.14%
Cash From Investing Activities $3.010M -$3.590M
YoY Change -183.84% -9075.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -470.0K -490.0K
YoY Change -4.08% 8.89%
NET CHANGE
Cash From Operating Activities 4.090M 4.440M
Cash From Investing Activities 3.010M -3.590M
Cash From Financing Activities -470.0K -490.0K
Net Change In Cash 6.630M 360.0K
YoY Change 1741.67% -54.43%
FREE CASH FLOW
Cash From Operating Activities $4.090M $4.440M
Capital Expenditures -$880.0K -$850.0K
Free Cash Flow $4.970M $5.290M
YoY Change -6.05% 204.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 alot Debt Received Upon Sale Of Operation
DebtReceivedUponSaleOfOperation
1000000
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7340736 shares
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13272000
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2297659 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
732736 shares
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29535000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12203000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.70
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
480023 shares
CY2015Q4 us-gaap Loans Receivable Basis Spread On Variable Rate
LoansReceivableBasisSpreadOnVariableRate
0.02 pure
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9601043 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.42
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3852000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
44718000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2912000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
66609000
CY2015Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
10000000
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
748000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
653000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
481000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5375000
CY2015Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1070000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2379000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
41897000
CY2015Q4 us-gaap Liabilities
Liabilities
13338000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79947000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
480000
CY2015Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1056000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-828000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
65000
CY2015Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
253000
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1980934
CY2015Q4 us-gaap Notes Receivable Net
NotesReceivableNet
253000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10746000
CY2015Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
92000
CY2015Q4 us-gaap Assets
Assets
79947000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
774000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
715000
CY2015Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
14719000
CY2015Q4 us-gaap Inventory Net
InventoryNet
15124000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14913000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
152000
CY2015Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
9945000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9416000
CY2015Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
11159000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
802000
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
19658000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
59785000
CY2015Q4 us-gaap Inventory Gross
InventoryGross
18976000
CY2015Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
3560000
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6880000
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8404000
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6132000
CY2015Q4 us-gaap Goodwill
Goodwill
4522000
CY2015Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
627000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3465000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11296000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
769000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38951000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2176189
CY2015Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
3425000
CY2015Q4 alot Revolving Line Of Credit Facility Issued Maximum Capacity
RevolvingLineOfCreditFacilityIssuedMaximumCapacity
600000
CY2015Q4 alot Amount Of Reserve For Settlement Of Liability
AmountOfReserveForSettlementOfLiability
291000
CY2015Q4 alot Product Replacement Cost Charged Against Reserve
ProductReplacementCostChargedAgainstReserve
381000
CY2015Q4 alot Line Of Credit Receivable Current
LineOfCreditReceivableCurrent
150000
CY2015Q4 alot Funded Debt To Adjusted Ebitda Ratio
FundedDebtToAdjustedEbitdaRatio
1.25 pure
CY2015Q4 alot Number Of Installments
NumberOfInstallments
16 Installment
CY2015Q4 alot Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
3 pure
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8341000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
656011 shares
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
2293606 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.01
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9544864 shares
CY2015Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3155000
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
43600000
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3302000
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
63511000
CY2015Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
402000
CY2015Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
707000
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
621000
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3155000
CY2015Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1167000
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2343000
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39735000
CY2015Q1 us-gaap Liabilities
Liabilities
10819000
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74330000
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
477000
CY2015Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
148000
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28444000
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9569000
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-699000
CY2015Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
83000
CY2015Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
255000
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3225000
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4033000
CY2015Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
88000
CY2015Q1 us-gaap Assets
Assets
74330000
CY2015Q1 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
18202000
CY2015Q1 us-gaap Inventory Net
InventoryNet
15582000
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14107000
CY2015Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
10600000
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8379000
CY2015Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
15174000
CY2015Q1 us-gaap Treasury Stock Value
TreasuryStockValue
19602000
CY2015Q1 us-gaap Assets Current
AssetsCurrent
61918000
CY2015Q1 us-gaap Inventory Gross
InventoryGross
18737000
CY2015Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
3028000
CY2015Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3100000
CY2015Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
256000
CY2015Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7372000
CY2015Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2698000
CY2015Q1 us-gaap Goodwill
Goodwill
991000
CY2015Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
765000
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4140000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7958000
CY2015Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36823000
CY2015Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2629000
CY2015Q1 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
1900000
CY2015Q1 alot Line Of Credit Receivable Current
LineOfCreditReceivableCurrent
173000
CY2012Q1 alot Loan Receivable Interest Rate Stated Percentage
LoanReceivableInterestRateStatedPercentage
0.0375 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2003000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
155000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.268 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.020 pure
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
219310 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.21
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7897000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7678000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.87
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.352 pure
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1719000
us-gaap Net Income Loss
NetIncomeLoss
4118000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-356000
us-gaap Sales Revenue Net
SalesRevenueNet
66277000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1619000
us-gaap Operating Income Loss
OperatingIncomeLoss
6438000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1245000
us-gaap Gross Profit
GrossProfit
28376000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-85000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2400000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-8000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3762000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-348000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6353000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3602000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1004000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
9462000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2235000
us-gaap Share Based Compensation
ShareBasedCompensation
381000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13483000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4931000
us-gaap Operating Expenses
OperatingExpenses
21938000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
3807000
us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
248000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-660000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4414000
us-gaap Decrease In Restricted Cash
DecreaseInRestrictedCash
1800000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1984000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
174000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
959000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4041000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1349000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-219000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
10585000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
526000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
37901000
us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
5000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1541000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-23000
us-gaap Restricted Stock Expense
RestrictedStockExpense
202000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
alot Income Tax Benefit Favorable Resolution Of Previously Uncertain Tax Position
IncomeTaxBenefitFavorableResolutionOfPreviouslyUncertainTaxPosition
141000
alot Proceeds From Disposition Of Inventory
ProceedsFromDispositionOfInventory
2355000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(1) Overview</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Headquartered in West Warwick, Rhode Island, Astro-Med Inc. designs, develops, manufactures and distributes a broad range of specialty printers and data acquisition and analysis systems. Our products are distributed through our own sales force and authorized dealers in the United States. We also sell to customers outside of the United States primarily through our Company offices in Canada, Mexico, Europe and Southeast Asia as well as with independent dealers and representatives. Astro-Med&#x2019;s products are employed around the world in a wide range of aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation applications.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> On September&#xA0;25, 2015, the Company announced it will begin doing business as AstroNova on a worldwide basis. The name change is part of our plan to modernize the Company and effectively communicate our strategy. The AstroNova name and brand emphasizes our traditional strengths in aerospace and acknowledges our expanding presence in test&#xA0;and measurement, product identification and other new areas where we can apply our data visualization technology. Astro-Med&#x2019;s Ruggedized products and Test and Measurement business will adopt the AstroNova brand. QuickLabel&#xA0;Systems products will continue to go to market under the QuickLabel<sup style="FONT-SIZE: 11px; VERTICAL-ALIGN: top">&#xAE;</sup>&#xA0;brand.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company has filed for trademark protection of the AstroNova name and logo in the United States and other countries.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The Company will continue to trade on NASDAQ stock exchange under its official name, Astro-Med, Inc., using its present ticker symbol, ALOT.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Unless otherwise indicated, references to &#x201C;Astro-Med,&#x201D; the &#x201C;Company,&#x201D; &#x201C;we,&#x201D; &#x201C;our,&#x201D; and &#x201C;us&#x201D; in this Quarterly Report on Form&#xA0;10-Q refer to Astro-Med, Inc. and its consolidated subsidiaries.</p> </div>
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
8245000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
Any borrowings made under this line of credit bear interest at either a fluctuating base rate equal to the highest of (i) the Prime Rate, (ii) 1.50% above the daily one month LIBOR, and (iii) the Federal Funds Rate in effect plus 1.50% or at a fixed rate of LIBOR plus an agreed upon margin of between 0% and 2.25%, based on the Company's funded debt to EBITDA ratio as defined in the agreement.
dei Amendment Flag
AmendmentFlag
false
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
700 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
424100 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000008146
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12.61
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.020 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
7.93
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.227 pure
us-gaap Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
0.155 pure
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2016-01-31
dei Entity Registrant Name
EntityRegistrantName
ASTRO MED INC /NEW/
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.98
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
185058 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.21
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7462000 shares
us-gaap Line Of Credit Facility Expiration Period
LineOfCreditFacilityExpirationPeriod
P3Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
110000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
2093 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.95
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7277000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.43
dei Document Period End Date
DocumentPeriodEndDate
2015-10-31
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
30482 shares
dei Trading Symbol
TradingSymbol
ALOT
us-gaap Fair Value Measurements Significant Assumptions
FairValueMeasurementsSignificantAssumptions
Key assumptions include (1) a weighted average cost of capital of 15.5%; (2) a range of earnings projections from $110,000-$700,000 and (3) a range of contract renewal probability from 0%-100%.
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1534000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.355 pure
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2173000
us-gaap Net Income Loss
NetIncomeLoss
3697000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-129000
us-gaap Sales Revenue Net
SalesRevenueNet
70897000
us-gaap Operating Income Loss
OperatingIncomeLoss
5141000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-457000
us-gaap Gross Profit
GrossProfit
29028000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
587000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
7360000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
756000
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-3000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-9000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3568000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-120000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5728000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
711000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
597000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
3692000
us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2031000
us-gaap Share Based Compensation
ShareBasedCompensation
834000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13555000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3338000
us-gaap Operating Expenses
OperatingExpenses
23887000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3564000
us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
270000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1303000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5200000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1856000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
212000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
231000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5132000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2101000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-40000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
7693000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
347000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
41869000
us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
8000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1467000
us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
135000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-814000
us-gaap Restricted Stock Expense
RestrictedStockExpense
614000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
1698000
alot Non Employee Director Received Restricted Stock Award Value
NonEmployeeDirectorReceivedRestrictedStockAwardValue
20000
alot Loan Receivable Date Considered For Interest Payments
LoanReceivableDateConsideredForInterestPayments
2013-01-30
alot Reservation Of Shares Under Employee Stock Purchase Plan
ReservationOfSharesUnderEmployeeStockPurchasePlan
247500 shares
alot Maximum Disposal Restriction As Percentage Of Restricted Stock Units
MaximumDisposalRestrictionAsPercentageOfRestrictedStockUnits
0.50 pure
alot Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
2 Equity_Plan
alot Period To Receive Lower Product Prices From Supplier Description
PeriodToReceiveLowerProductPricesFromSupplierDescription
Through fiscal 2017
CY2014Q1 alot Settlement Amount Received From Supplier For Recovery Of Cost And Expenses
SettlementAmountReceivedFromSupplierForRecoveryOfCostAndExpenses
450000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y2M12D
CY2013Q2 alot Estimated Replacement Cost Of Product
EstimatedReplacementCostOfProduct
672000
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2014Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
155000 shares
CY2014Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
196620 shares
CY2014Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2014Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.385 pure
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
1555000
CY2014Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7926000 shares
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7730000 shares
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2014Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-313000
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
23137000
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
2575000
CY2014Q4 us-gaap Gross Profit
GrossProfit
10152000
CY2014Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-46000
CY2014Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6000
CY2014Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1242000
CY2014Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-307000
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2529000
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
974000
CY2014Q4 us-gaap Share Based Compensation
ShareBasedCompensation
122000
CY2014Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4606000
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
7577000
CY2014Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1564000
CY2014Q4 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
62000
CY2014Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1407000
CY2014Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
175000
CY2014Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
12985000
CY2014Q4 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
2000
CY2014Q4 us-gaap Restricted Stock Expense
RestrictedStockExpense
58000
CY2014Q4 alot Income Tax Benefit Favorable Resolution Of Previously Uncertain Tax Position
IncomeTaxBenefitFavorableResolutionOfPreviouslyUncertainTaxPosition
41000
CY2015Q3 alot Fees To Non Employee Director
FeesToNonEmployeeDirector
7000
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2015Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
449100 shares
CY2015Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
171557 shares
CY2015Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2015Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7466000 shares
CY2015Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7295000 shares
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2015Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.398 pure
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
1319000
CY2015Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000
CY2015Q4 us-gaap Sales Revenue Net
SalesRevenueNet
24753000
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1859000
CY2015Q4 us-gaap Gross Profit
GrossProfit
10152000
CY2015Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
333000
CY2015Q4 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-3000
CY2015Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000
CY2015Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1318000
CY2015Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000
CY2015Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2192000
CY2015Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
873000
CY2015Q4 us-gaap Share Based Compensation
ShareBasedCompensation
391000
CY2015Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4563000
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
8293000
CY2015Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1839000
CY2015Q4 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
69000
CY2015Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1891000
CY2015Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
152000
CY2015Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
14601000
CY2015Q4 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
4000
CY2015Q4 us-gaap Restricted Stock Expense
RestrictedStockExpense
318000

Files In Submission

Name View Source Status
R32.htm Edgar Link pending
0001193125-15-401329-index-headers.html Edgar Link pending
0001193125-15-401329-index.html Edgar Link pending
0001193125-15-401329.txt Edgar Link pending
0001193125-15-401329-xbrl.zip Edgar Link pending
alot-20151031.xml Edgar Link completed
alot-20151031.xsd Edgar Link pending
alot-20151031_cal.xml Edgar Link unprocessable
alot-20151031_def.xml Edgar Link unprocessable
alot-20151031_lab.xml Edgar Link unprocessable
alot-20151031_pre.xml Edgar Link unprocessable
d14196d10q.htm Edgar Link pending
d14196dex101.htm Edgar Link pending
d14196dex311.htm Edgar Link pending
d14196dex312.htm Edgar Link pending
d14196dex321.htm Edgar Link pending
d14196dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending